x

Search for a clinical trial

* (*) mandatory field

Role of GLP-1 In Congenital Hyperinsulinism: Effect of Exendin-(9-39) on Glucose Requirements To Maintain Euglycemia (Phase 1/2) - US

  • Type of clinical trial : Drug clinical trial
  • Recruiting project : Yes
  • Status : Ongoing trial
  • Funded by an IRDiRC member
  • Funding body(ies) :
  • ORPHAN PRODUCTS GRANTS PROGRAM (FDA)
  • Geographic coverage : National
  • Sponsor : De leon
  • Website
    • Phase : I - II
  • Principal investigator of clinical trial

  • Dr Diva DE LEON
  • Center of Congenital Hyperinsulinism
  • The Children's Hospital of Philadelphia
  • 34th Street and Civic Center Boulevard
  • PHILADELPHIA PA 19104-4399
  • UNITED STATES
  • More information
  • Phone  : -
  • Fax  : -
  • Website
  • Sponsor of clinical trial

  • Dr Diva DE LEON
  • Center of Congenital Hyperinsulinism
  • The Children's Hospital of Philadelphia
  • 34th Street and Civic Center Boulevard
  • PHILADELPHIA PA 19104-4399
  • UNITED STATES
  • More information
  • Phone  : -
  • Fax  : -
  • Website
Last update: February 2014

Additional information

The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.